Patients with a suboptimal response to a treatment course with a selective-serotonin reuptake inhibitor, serotonin and norepinephrine reuptake inhibitor, or mirtazapine that met or exceeded minimal standards for dose and duration of treatment were eligible (Supplement 2).15 Suboptimal response was defined...